In clinical studies, a significant percentage of participants reported nausea
This information is valuable for both self-management and discussions with your healthcare provider
But a newer drug called retatrutide is generating real excitement in the medical community, and for good reason
Late 2024 had already seen the launch of the first generic exenatide, and in August 2025 the FDA approved the first generic version of liraglutide (Saxenda) for weight loss, with Teva launching immediately
With this approach, you still receive the core benefits of semaglutide: Appetite regulation Improved metabolic function Sustainable weight loss Better long-term adherence due to fewer side effects Its a smarter, more personalized way to use semaglutide designed to work with your body, not against it
Oral formulations enter the bloodstream more gradually, potentially easing initial nausea for sensitive patients